Orbit develop and apply innovative drug discovery platforms defined by a unique peptide display engine that deliver novel, functional, biologically relevant peptide therapeutic leads.
The Orbit peptide display engine is uniquely able to address cell-based targets and thereby screen targets in relevant contexts.
Peptide leads are key starting points for the development of peptide, peptidomimetic and small molecule therapeutics as well as bioconjugates for cell targeting and cargo delivery.
Founded in late 2015 as a spin-out from Oxford University based on the work of Professors Graham Ogg and Terry Rabbitts. We have a pipeline of novel targets in in-house programmes and we work in collaboration with others in industry and academia to make our technology as accessible as possible.
|
|
|
11-50 employees
View all Orbit Discovery employees
|
|
Biotechnology
|
|
+44 (0)1865 749234
|
|
Heatley Road, Oxford, GB
|
|
2015
|
|
Transcription, Drug Discovery, Translation, Peptide Drugs, Cell-Surface Targets, Constrained Peptides, Non-Natural Amino Acids, Peptide Display, Transcription/Translation On Bead
|
Neil Butt is the CEO of Orbit Discovery. To contact Neil Butt email at [email protected].
The decision makers in Orbit Discovery are Alex Batchelor, Brett Rowley, Caroline W, etc. Click to Find Orbit Discovery decision makers emails.
You can reach out to Orbit Discovery through their contact form on the website or by emailing [email protected]. For urgent inquiries, consider calling their office directly. Their team is ready to assist with any questions regarding their innovative drug discovery platforms.
Orbit Discovery's key staff members are listed on their website under the 'Team' section. Each profile includes a brief bio and contact information. For specific inquiries, you can also reach out to the general contact email provided on the site.
Orbit Discovery supports various industries, including pharmaceuticals, biotechnology, and academic research. Their peptide display technology is designed to facilitate drug discovery, particularly for cell-surface targets, providing innovative solutions for developing peptide therapeutics.
Yes, you can schedule a consultation by contacting Orbit Discovery through their website's contact form or by emailing their business development team. They are open to discussing potential collaborations and partnerships in drug discovery and peptide development.
Orbit Discovery offers a range of drug discovery solutions, including peptide drug development, screening for cell-based targets, and the application of their unique peptide display engine. Their focus is on delivering biologically relevant peptide therapeutic leads for various applications.
Orbit Discovery's peptide display engine uniquely targets cell-based applications, enabling the screening of biologically relevant peptides more effectively than traditional methods. This innovative approach allows for the discovery of constrained peptides and non-natural amino acids, enhancing therapeutic lead development.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.